CG Oncology, Inc. Common stock (CGON) is a publicly traded Healthcare sector company. As of July 14, 2026, CGON trades at $71.69 with a market cap of $6.39B and a P/E ratio of -30.66. CGON moved -1.19% today. Year to date, CGON is +72.86%; over the trailing twelve months it is +177.10%. Its 52-week range spans $14.80 to $77.00. Analyst consensus is strong buy with an average price target of $91.55. Rallies surfaces CGON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CGON combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $71.69 |
| Market Cap | $6.39B |
| P/E Ratio | -30.66 |
| EPS | $-2.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $77.00 |
| 52-Week Low | $14.80 |
| Volume | 595.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.07M |
| Net Income | $-186.75M |
| Gross Margin | 0.00% |
14 analysts cover CGON: 0 strong buy, 13 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.55.